IMAX (IMAX) has just posted its Q2 2026 scorecard, with revenue of US$102.8 million and basic EPS of US$0.28, setting the tone for how investors assess the latest quarter. The company has seen quarterly revenue move from US$91.7 million in Q2 2025 to US$102.8 million in Q2 2026, while basic EPS over the same periods shifted from US$0.21 to US$0.28 as IMAX worked this performance into a trailing twelve month net profit margin of 9.8%. This has left investors focused on how durable that profitability profile looks.
See our full analysis for IMAX.With the headline numbers on the table, the next step is to line them up against the prevailing IMAX narratives to see which stories the latest margins support and which they put under pressure.
See what the community is saying about IMAX
To see how these results tie into long-term growth, risks, and valuation, check out the full range of community narratives for IMAX on Simply Wall St. Add the company to your watchlist or portfolio so you'll be alerted when the story evolves.
If the mix of optimism and caution around IMAX feels finely balanced, do not wait on others to decide for you. Instead, take a closer look at the 3 key rewards and 1 important warning sign
For IMAX, relatively modest revenue growth expectations against a higher US benchmark and a premium 58.1x P/E suggest the stock carries meaningful valuation risk.
If IMAX's rich multiple and forecast tension make you uneasy, it is worth promptly comparing that profile with companies screened for 81 resilient stocks with low risk scores that may better match your comfort level.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com